nach oben

Erschienen in:

01.05.2014 | Review

Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery

verfasst von: M. Jacobs, R. C. Macefield, R. G. Elbers, K. Sitnikova, I. J. Korfage, E. M. A. Smets, I. Henselmans, M. I. van Berge Henegouwen, J. C. J. M. de Haes, J. M. Blazeby, M. A. G. Sprangers

Erschienen in: Quality of Life Research | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study is to (1) estimate the direction, clinical relevance, and duration of health-related quality of life (HRQL) change in the first year following esophageal cancer surgery and (2) to assess the robustness of the estimates by subgroup and sensitivity analyses, and an exploration of publication bias.

Methods

A systematic literature search in MEDLINE, EMBASE, CINAHL, PsychINFO, and CENTRAL to identify randomized and non-randomized studies was performed. We compared the baseline HRQL data with 3-, 6-, 9-, or 12-month follow-ups to estimate the magnitude and duration of HRQL change. These estimates were then classified as trivial, small, medium, or large. Primary outcomes were role functioning, eating, and fatigue. Secondary outcomes were physical and social functioning, dysphagia, pain, and coughing problems. We conducted subgroup analysis for open surgery, open surgery preceded by neo-adjuvant therapy, and minimally invasive surgery. Sensitivity analyses assessed the influence of study design, transformation/imputation of the data, and HRQL questionnaire used.

Results

We included data from 15 studies to estimate the change in 28 HRQL outcomes after esophageal cancer surgery. The main analysis showed that patients’ social functioning deteriorated. Symptoms of fatigue, pain, and coughing problems increased. These changes lasted for 9–12 months, although some symptoms persisted beyond the first year after surgery. For many other HRQL outcomes, estimates were only robust after subgroup or sensitivity analyses (e.g., role and physical functioning), or remained too heterogeneous to interpret (e.g., eating and dysphagia).

Conclusions

Patients will experience a clinically relevant and long-lasting deterioration in HRQL after esophageal cancer surgery. However, for many HRQL outcomes, more and better quality evidence is needed.

Nur mit Berechtigung zugänglich

A large change indicates a clear clinical relevance. A medium change indicates a clinical relevance, but to a lesser extent. A small change indicates a subtle but nevertheless clinically relevant effect. A trivial change indicates either a change of unlikely clinical relevance, or no change.

QLQ-C30: global quality of life, physical functioning, role functioning, cognitive functioning, emotional functioning, social functioning, fatigue, nausea and vomiting, insomnia, constipation, pain, diarrhea, appetite loss, dyspnoea, and financial difficulties. QLQ-OES18: dysphagia, eating, reflux, swallowing saliva, choking when swallowing, speech, taste problems, and coughing problems. QLQ-OES24: deglutition, alopecia, trouble talking, emotional problems/anxiety. SF-36: role physical, role emotional, bodily pain, mental health, and vitality. FACT-E: physical well-being, functional well-being, social/family well-being, emotional well-being, oesophageal cancer subscale, fact-E total, and fact-G total. a-RSCL: psychological symptoms, physical symptoms, and activity level. MOS-SF-20: health perceptions, energy, and bodily pain.

QLQ-C30: global quality of life, physical functioning, role functioning, cognitive functioning, emotional functioning, social functioning, fatigue, nausea and vomiting, insomnia, constipation, pain, diarrhea, appetite loss, dyspnoea, and financial difficulties. QLQ-OES18: dysphagia, eating, reflux, pain, swallowing saliva, choking when swallowing, speech problems, taste problems, and coughing problems. QLQ-OES24: deglutition. SF-36: role functioning and social functioning. FACT-E: fact-E. A-RSCL: global quality of life. MOS-SF-20: physical functioning, role functioning, and social functioning.

Gebski, V., Burmeister, B., Smithers, B. M., Foo, K., Zalcberg, J., & Simes, J. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. The Lancet Oncology, 8(3), 226–234.PubMedCrossRef

Rutegard, M., Charonis, K., Lu, Y., Lagergren, P., Lagergren, J., & Rouvelas, I. (2012). Population-based esophageal cancer survival after resection without neoadjuvant therapy: An update. Surgery, 152(2), 903–910.PubMedCrossRef

Van, H. P., Hulshof, M. C., van Lanschot, J. J., Steyerberg, E. W., van Berge Henegouwen, M. I., Wijnhoven, B. P., et al. (2012). Preoperative chemoradiotherapy for esophageal or junctional cancer. New England Journal of Medicine, 366(22), 2074–2084.CrossRef

Djarv, T., & Lagergren, P. (2012). Quality of life after esophagectomy for cancer. Expert Review of Gastroenterology & Hepatology, 6(1), 115–122.CrossRef

Trask, P. C., Hsu, M. A., & McQuellon, R. (2009). Other paradigms: Health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer Journal, 15(5), 435–440.CrossRef

Henselmans, I., Jacobs, M., van Berge Henegouwen, M. I., de Haes, H. C., Sprangers, M. A., & Smets, E. M. (2012). Postoperative information needs and communication barriers of esophageal cancer patients. Patient Education and Counseling, 88(1), 138–146.PubMedCrossRef

Higgins J. P. T., & Green, S. (Eds.). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Accessed August 27, 2012.

Guyatt, G. H., Oxman, A. D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., et al. (2011). GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). Journal of Clinical Epidemiology, 64(4), 407–415.PubMedCrossRef

Whistance, R. N., & Blazeby, J. M. (2011). Systematic review: Quality of life after treatment for upper gastrointestinal cancer. Current Opinion in Supportive and Palliative Care, 5(1), 37–46.PubMedCrossRef

10.

Conroy, T., Marchal, F., & Blazeby, J. M. (2006). Quality of life in patients with oesophageal and gastric cancer: An overview. Oncology, 70(6), 391–402.PubMedCrossRef

11.

Parameswaran, R., McNair, A., Avery, K. N., Berrisford, R. G., Wajed, S. A., Sprangers, M. A., et al. (2008). The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: A systematic review. Annals of Surgical Oncology, 15(9), 2372–2379.PubMedCrossRef

12.

Sanghera, S. S., Nurkin, S. J., & Demmy, T. L. (2012). Quality of life after an esophagectomy. Surgical Clinics of North America, 92(5), 1315–1335.PubMedCrossRef

13.

Fernandez, F. G., & Meyers, B. F. (2004). Quality of life after esophagectomy. Seminars in Thoracic and Cardiovascular Surgery, 16(2), 152–159.PubMedCrossRef

14.

Jacobs, M., Macefield, R. C., Blazeby, J. M., Korfage, I. J., van Berge Henegouwen, M. I., de Haes, H. C., et al. (2012). Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Quality of Life Research,. doi:10.1007/s11136-012-0290-8.

15.

Borenstein, M., Hedges, L. V., Higgins, J. P., & Rothstein, H. R. (2009). Introduction to meta-analysis. Chichester: Wiley.CrossRef

16.

Scarpa, M., Valente, S., Alfieri, R., Cagol, M., Diamantis, G., Ancona, E., et al. (2011). Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World Journal of Gastroenterology, 17(42), 4660–4674.PubMedCentralPubMedCrossRef

17.

Maringwa, J. T., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.PubMedCrossRef

18.

Shrier, I., Boivin, J. F., Steele, R. J., Platt, R. W., Furlan, A., Kakuma, R., et al. (2007). Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. American Journal of Epidemiology, 166(10), 1203–1209.PubMedCrossRef

19.

Ioannidis, J. P., Patsopoulos, N. A., & Rothstein, H. R. (2008). Reasons or excuses for avoiding meta-analysis in forest plots. British Medical Journal, 336(7658), 1413–1415.PubMedCentralPubMedCrossRef

20.

Vandenbroucke, J. P. (2011). Why do the results of randomised and observational studies differ? British Medical Journal, 343, d7020.PubMedCrossRef

21.

Avery, K. N., Metcalfe, C., Barham, C. P., Alderson, D., Falk, S. J., & Blazeby, J. M. (2007). Quality of life during potentially curative treatment for locally advanced oesophageal cancer. British Journal of Surgery, 94(11), 1369–1376.PubMedCrossRef

22.

Howick, J., Chalmers, I., Glasziou, P., Greenhalgh, T., Heneghan, C., Liberati, A. et al. (2011). Explanation of the 2011 Oxford centre for evidence-based medicine (OCEBM) levels of evidence (Background Document). Oxford centre for evidence-based medicine. http://www.cebm.net/index.aspx?o=5653. Accessed 27 August 2012.

23.

Efficace, F., Bottomley, A., Osoba, D., Gotay, C., Flechtner, H., D’haese, S., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21, 3502–3511.PubMedCrossRef

24.

Blazeby, J. M., Conroy, T., Hammerlid, E., Fayers, P., Sezer, O., Koller, M., et al. (2003). Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. European Journal of Cancer, 39(10), 1384–1394.PubMedCrossRef

25.

Blazeby, J. M., Alderson, D., Winstone, K., Steyn, R., Hammerlid, E., Arraras, J., et al. (1996). Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. European Journal of Cancer, 32(11), 1912–1917.CrossRef

26.

DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188.PubMedCrossRef

27.

Riley, R. D., Higgins, J. P., & Deeks, J. J. (2011). Interpretation of random effects meta-analyses. British Medical Journal, 342, d549.PubMedCrossRef

28.

Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. British Medical Journal, 327(7414), 557–560.PubMedCentralPubMedCrossRef

29.

Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558.PubMedCrossRef

30.

Ioannidis, J. P., Patsopoulos, N. A., & Evangelou, E. (2007). Uncertainty in heterogeneity estimates in meta-analyses. British Medical Journal, 335(7626), 914–916.PubMedCentralPubMedCrossRef

31.

Cocks, K., King, M. T., Velikova, G., de, C. G., Jr., Martyn St-James, M., & Fayers, P. M. et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.

32.

Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.PubMed

33.

Cohen, J. (1988). Statistical power analysis in the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates Inc.

34.

Boshier, P. R., Anderson, O., & Hanna, G. B. (2011). Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: A meta-analysis. Annals of Surgery, 254(6), 894–906.PubMedCrossRef

35.

Hulscher, J. B., van Sandick, J. W., de Boer, A. G., Wijnhoven, B. P., Tijssen, J. G., Fockens, P., et al. (2002). Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine, 347(21), 1662–1669.PubMedCrossRef

36.

Chang, A. C., Ji, H., Birkmeyer, N. J., Orringer, M. B., & Birkmeyer, J. D. (2008). Outcomes after transhiatal and transthoracic esophagectomy for cancer. Annals of Thoracic Surgery, 85(2), 424–429.PubMedCrossRef

37.

Rutegard, M., Lagergren, J., Rouvelas, I., Lindblad, M., Blazeby, J. M., & Lagergren, P. (2008). Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. British Journal of Surgery, 95(5), 592–601.PubMedCrossRef

38.

Yang, K., Chen, H. N., Chen, X. Z., Lu, Q. C., Pan, L., Liu, J., et al. (2012). Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: A meta-analysis. PLoS ONE, 7(6), e37698.PubMedCentralPubMedCrossRef

39.

Sjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., et al. (2011). Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis. The Lancet Oncology, 12(7), 681–692.PubMedCrossRef

40.

Fedeli, U., Schievano, E., & Lisiero, M. (2012). Mortality after esophageal and gastric cancer resection. World Journal of Surgery, 36(11), 2630–2636.PubMedCrossRef

41.

Biere, S. S., Maas, K. W., Bonavina, L., Garcia, J. R., van Berge Henegouwen, M. I., Rosman, C., et al. (2011). Traditional invasive versus minimally invasive esophagectomy: A multi-center, randomized trial (TIME-trial). British Medical Journal Surgery, 11, 2.

42.

Shah, R., & Jobe, B. A. (2011). Open versus minimally invasive esophagectomy: What is the best approach? Minimally invasive esophagectomy. Journal of Gastrointestinal Surgery, 15(9), 1503–1505.PubMedCrossRef

43.

Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463.PubMedCrossRef

44.

Rosenthal, R. (1979). The ‘file drawer problem’ and tolerance for null results. Psychological Bulletin, 86, 638–641.CrossRef

45.

Egger, M., Davey, S. G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315(7109), 629–634.PubMedCentralPubMedCrossRef

46.

Teoh, A. Y., Yan Chiu, P. W., Wong, T. C., Liu, S. Y., Hung Wong, S. K., & Ng, E. K. (2011). Functional performance and quality of life in patients with squamous esophageal carcinoma receiving surgery or chemoradiation: Results from a randomized trial. Annals of Surgery, 253(1), 1–5.PubMedCrossRef

47.

Nafteux, P., Moons, J., Coosemans, W., Decaluwe, H., Decker, G., De, L. P., et al. (2011). Minimally invasive oesophagectomy: A valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinoma. European Journal of Cardio-Thoracic Surgery, 40(6), 1455–1463.PubMed

48.

Parameswaran, R., Blazeby, J. M., Hughes, R., Mitchell, K., Berrisford, R. G., & Wajed, S. A. (2010). Health-related quality of life after minimally invasive oesophagectomy. British Journal of Surgery, 97(4), 525–531.PubMedCrossRef

49.

Wang, H., Tan, L., Feng, M., Zhang, Y., & Wang, Q. (2011). Comparison of the short-term health-related quality of life in patients with esophageal cancer with different routes of gastric tube reconstruction after minimally invasive esophagectomy. Quality of Life Research, 20(2), 179–189.PubMedCrossRef

50.

Wang, H., Feng, M., Tan, L., & Wang, Q. (2010). Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Diseases of the Esophagus, 23(5), 408–414.PubMed

51.

Safieddine, N., Xu, W., Quadri, S. M., Knox, J. J., Hornby, J., Sulman, J., et al. (2009). Health-related quality of life in esophageal cancer: Effect of neoadjuvant chemoradiotherapy followed by surgical intervention. Journal of Thoracic and Cardiovascular Surgery, 137(1), 36–42.PubMedCrossRef

52.

van Meerten, E., van der Gaast, A., Looman, C. W., Tilanus, H. W., Muller, K., & Essink-Bot, M. L. (2008). Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. International Journal of Radiation Oncology Biology Physics, 71(1), 160–166.CrossRef

53.

Barbour, A. P., Lagergren, P., Hughes, R., Alderson, D., Barham, C. P., & Blazeby, J. M. (2008). Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. British Journal of Surgery, 95(1), 80–84.PubMedCrossRef

54.

Lagergren, P., Avery, K. N. L., Hughes, R., Barham, C. P., Alderson, D., Falk, S. J. et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer, 110(3), 686–693.

55.

Tan, Q. Y., Wang, R. W., Jiang, Y. G., Fan, S. Z., Hsin, M. K., Gong, T. Q., et al. (2006). Lung volume reduction surgery allows esophageal tumor resection in selected esophageal carcinoma with severe emphysema. Annals of Thoracic Surgery, 82(5), 1849–1856.PubMedCrossRef

56.

Reynolds, J. V., McLaughlin, R., Moore, J., Rowley, S., Ravi, N., & Byrne, P. J. (2006). Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. British Journal of Surgery, 93(9), 1084–1090.PubMedCrossRef

57.

de Boer, A. G., van Lanschot, J. J., van Sandick, J. W., Hulscher, J. B., Stalmeier, P. F., de Haes, J. C., et al. (2004). Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. Journal of Clinical Oncology, 22(20), 4202–4208.PubMedCrossRef

58.

Brooks, J. A., Kesler, K. A., Johnson, C. S., Ciaccia, D., & Brown, J. W. (2002). Prospective analysis of quality of life after surgical resection for esophageal cancer: Preliminary results. Journal of Surgical Oncology, 81(4), 185–194.PubMedCrossRef

59.

Scarpa, M., Saadeh, L. M., Fasolo, A., Alfieri, R., Cagol, M., Cavallin, F., et al. (2013). Health-related quality of life in patients with oesophageal cancer: Analysis at different steps of the treatment pathway. Journal of Gastrointestinal Surgery,. doi:10.1007/s11605-012-2069-1.

60.

Biere, S. S., van Berge Henegouwen, M. I., Maas, K. W., Bonavina, L., Rosman, C., Garcia, J. R., et al. (2012). Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open-label, randomised controlled trial. Lancet, 379(9829), 1887–1892.PubMedCrossRef

61.

Briez, N., Piessen, G., Bonnetain, F., Brigand, C., Carrere, N., Collet, D., et al. (2011). Open versus laparoscopically-assisted oesophagectomy for cancer: A multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer, 11(310), 310.PubMedCentralPubMedCrossRef

62.

Zhang, C., Wu, Q. C., Hou, P. Y., Zhang, M., Li, Q., Jiang, Y. J., et al. (2011). Impact of the method of reconstruction after oncologic oesophagectomy on quality of life—a prospective, randomised study. European Journal of Cardio-Thoracic Surgery, 39(1), 109–114.PubMedCrossRef

63.

Steyerberg, E. W. (2009). Clinical prediction models. New York: Springer.CrossRef

64.

Derogar, M., Orsini, N., Sadr-Azodi, O., & Lagergren, P. (2012). Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. Journal of Clinical Oncology, 30(14), 1615–1619.PubMedCrossRef

65.

Sprangers, M. A., Sloan, J. A., Barsevick, A., Chauhan, C., Dueck, A. C., Raat, H., et al. (2010). Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of Life Research, 19(10), 1395–1403.PubMedCentralPubMedCrossRef

66.

Lagergren, J., & Lagergren, P. (2013). Recent developments in esophageal adenocarcinoma. CA: A Cancer Journal for Clinicians,. doi:10.1002/caac.21185.

67.

Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Juni, P., Altman, D. G., et al. (2008). Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. British Medical Journal, 336(7644), 601–605.PubMedCentralPubMedCrossRef

68.

Moher, D., Pham, B., Lawson, M. L., & Klassen, T. P. (2003). The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technology Assessment, 7(41), 1–90.PubMed

Titel: Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery
verfasst von: M. Jacobs
R. C. Macefield
R. G. Elbers
K. Sitnikova
I. J. Korfage
E. M. A. Smets
I. Henselmans
M. I. van Berge Henegouwen
J. C. J. M. de Haes
J. M. Blazeby
M. A. G. Sprangers
Publikationsdatum: 01.05.2014
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 4/2014
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-013-0545-z

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Letter to the Editor: Concerning Paltzer, Jason, Emily Barker, and Whitney P. Witt: Measuring the health-related quality of life (HRQoL) of young children in resource-limited settings: a review of existing measures, Quality of Life Research

Thirty years of portraying oral health through models: what have we accomplished in oral health-related quality of life research?

Identifying vulnerability in grief: psychometric properties of the Adult Attitude to Grief Scale

Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0

Item reduction of the Wisconsin Upper Respiratory Symptom Survey (WURSS-21) leads to the WURSS-11

Masticatory factors as predictors of oral health-related quality of life among elderly people in Kaohsiung City, Taiwan